Literature DB >> 3907590

Reversible and irreversible inhibition of rat brain muscarinic receptors is related to different substitutions on bisquaternary pyridinium oximes.

Y Kloog, R Galron, D Balderman, M Sokolovsky.   

Abstract

The role of the functional substituents on the pyridinium ring of bisquaternary pyridinium compounds, mostly oximes, in exerting reversible and irreversible inhibition of binding of [3H]-N-methyl-4-piperidyl benzilate [( 3H]-4NMPB) to rat brain stem muscarinic receptors was studied. The drugs tested, i.e. HGG-42, HGG-12, HGG-52, HI-6, obidoxim, SAD-128 and TMB-4, could reversibly inhibit binding of [3H]-4NMPB, with the highest potency (KI = 1.7 - 6 microM) exhibited by analogs possessing hydrophobic substituents at position 3 or 4 of the pyridinium ring. Bisquaternary drugs possessing an oxime moiety at position 2, but not at position 4 of the pyridinium ring, could also induce about 30% reduction of maximal binding capacity (Bmax) (loss of muscarinic receptors) in addition to their reversible effect. Thus the structural correlates of the reversible and the irreversible effects of these drugs are different.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907590     DOI: 10.1007/bf00292614

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  14 in total

1.  The dependence of the blood level of the oxime HS-6 on the severity of organophosphate poisoning.

Authors:  O L Wolthuis; H J Clason-Van Der Wiel; R Visser
Journal:  Eur J Pharmacol       Date:  1976-10       Impact factor: 4.432

2.  Structure-activity relationship of mono- and bisquaternary pyridines in regard to their parasympatholytic effects.

Authors:  D Kuhnen-Clausen
Journal:  Toxicol Appl Pharmacol       Date:  1972-11       Impact factor: 4.219

3.  Investigations on the parasympatholytic effect of toxogonin on the guinea-pig isolated ileum.

Authors:  D Kuhnen-Clausen
Journal:  Eur J Pharmacol       Date:  1970-01       Impact factor: 4.432

4.  Muscarinic receptors in the central nervous system.

Authors:  M Sokolovsky
Journal:  Int Rev Neurobiol       Date:  1984       Impact factor: 3.230

Review 5.  Anomalies in theories and therapy of intoxication by potent organophosphorus anticholinesterase compounds.

Authors:  R I Ellin
Journal:  Gen Pharmacol       Date:  1982

6.  The interaction of bis-pyridinium oximes with mouse brain muscarinic receptor.

Authors:  G Amitai; Y Kloog; D Balderman; M Sokolovsky
Journal:  Biochem Pharmacol       Date:  1980-02-15       Impact factor: 5.858

7.  Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization.

Authors:  Y Kloog; Y Egozi; M Sokolovsky
Journal:  Mol Pharmacol       Date:  1979-05       Impact factor: 4.436

8.  [Relation between chemical structure and cholinesterase-reactivating effect in a series of new asymmetric pyridinium salts. I. Derivatives of 4-hydroxyiminomethylpyridine].

Authors:  E Dirks; A Scherer; M Schmidt; G Zimmer
Journal:  Arzneimittelforschung       Date:  1970-01

9.  Interactions of bisquaternary pyridine salts (H-oximes) with cholinergic receptors.

Authors:  D Kuhnen-Clausen; I Hagedorn; G Gross; H Bayer; F Hucho
Journal:  Arch Toxicol       Date:  1983-11       Impact factor: 5.153

10.  Bisquaternary pyridinium oximes as allosteric inhibitors of rat brain muscarinic receptors.

Authors:  Y Kloog; M Sokolovsky
Journal:  Mol Pharmacol       Date:  1985-04       Impact factor: 4.436

View more
  4 in total

1.  Therapy of organophosphate poisoning in the rat by direct effects of oximes unrelated to ChE reactivation.

Authors:  H P van Helden; J de Lange; R W Busker; B P Melchers
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  Receptor-mediated presynaptic facilitation of quantal release of acetylcholine induced by pralidoxime in Aplysia.

Authors:  P Fossier; G Baux; B Poulain; L Tauc
Journal:  Cell Mol Neurobiol       Date:  1990-09       Impact factor: 5.046

3.  Non-reactivating effects of HI-6 on hippocampal neurotransmission.

Authors:  B P Melchers; A L van der Laaken; R W Busker; P L Bruijnzeel; H P Van Helden
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

4.  Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.

Authors:  H P van Helden; H J van der Wiel; J J Zijlstra; B P Melchers; R W Busker
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.